Figure 2.
Mean values of serum creatinine (mg/dL) in all experimental groups. Diabetes induction increased this value (p < 0.001), but empagliflozin therapy reduced it (p < 0.001) at days 36th (* (p < 0.001)) showing a significant difference when compared with the control (C) group; # (p < 0.001) and a significant difference when compared with the diabetic (D) group (1 = day 0 or first examination, 2 = day 36). (C = control, CE = control plus empagliflozin, D = diabetes, DE = diabetes plus empagliflozin).